Skip to main content
PMC home page
American Journal of Public Health logoLink to American Journal of Public Health
. 1993 Aug;83(8):1113–1120. doi: 10.2105/ajph.83.8.1113

Oral contraceptives and the risk of gallbladder disease: a meta-analysis.

C Thijs 1, P Knipschild 1
PMCID: PMC1695167  PMID: 8342719

Abstract

OBJECTIVES. This study was designed to assess the risk of gallbladder disease due to oral contraceptive use by conducting a thorough literature review. METHODS. Controlled epidemiologic studies published through March 1992 were systematically searched and evaluated. Of 25 studies (27 publications), 9 could stand the test of critical appraisal with respect to validity. Restriction to these studies was judged to circumvent publication bias at the same time. RESULTS. Oral contraceptive use is associated with a slightly and transiently increased rate of gallbladder disease. The results of six selected studies in which asymptomatic women were screened for gallstones were strikingly similar. Pooling of these results yielded an odds ratio, for ever vs never oral contraceptive use, of 1.36. A dose-effect relationship was indicated, suggesting that modern low-dose oral contraceptives are safer than older formulas, but an effect cannot be excluded. CONCLUSIONS. Considering the large efforts already devoted to this exposure-disease relationship, the probably weak effect, and the rapidly changing formulas of oral contraceptives, the authors suggest that the safety of new oral contraceptives be evaluated by studying bile saturation and biliary function rather than by waiting for gallbladder disease to develop.

Full text

PDF
1113

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ahlberg J. Serum lipid levels and hyperlipoproteinaemia in gallstone patients. Acta Chir Scand. 1979;145(6):373–377. [PubMed] [Google Scholar]
  2. Barbara L., Sama C., Morselli Labate A. M., Taroni F., Rusticali A. G., Festi D., Sapio C., Roda E., Banterle C., Puci A. A population study on the prevalence of gallstone disease: the Sirmione Study. Hepatology. 1987 Sep-Oct;7(5):913–917. doi: 10.1002/hep.1840070520. [DOI] [PubMed] [Google Scholar]
  3. Bennion L. J., Grundy S. M. Risk factors for the development of cholelithiasis in man (first of two parts). N Engl J Med. 1978 Nov 23;299(21):1161–1167. doi: 10.1056/NEJM197811232992104. [DOI] [PubMed] [Google Scholar]
  4. Braverman D. Z., Johnson M. L., Kern F., Jr Effects of pregnancy and contraceptive steroids on gallbladder function. N Engl J Med. 1980 Feb 14;302(7):362–364. doi: 10.1056/NEJM198002143020702. [DOI] [PubMed] [Google Scholar]
  5. Diehl A. K., Stern M. P., Ostrower V. S., Friedman P. C. Prevalence of clinical gallbladder disease in Mexican-American, Anglo, and black women. South Med J. 1980 Apr;73(4):438-41, 443. doi: 10.1097/00007611-198004000-00012. [DOI] [PubMed] [Google Scholar]
  6. Everson G. T., McKinley C., Lawson M., Johnson M., Kern F., Jr Gallbladder function in the human female: effect of the ovulatory cycle, pregnancy, and contraceptive steroids. Gastroenterology. 1982 Apr;82(4):711–719. [PubMed] [Google Scholar]
  7. Feinstein A. R. Para-analysis, faute de mieux, and the perils of riding on a data barge. J Clin Epidemiol. 1989;42(10):929–935. doi: 10.1016/0895-4356(89)90157-1. [DOI] [PubMed] [Google Scholar]
  8. Honoré L. H. Cholesterol cholelithiasis in adolescent females: its connection with obestiy, parity, and oral contraceptive use--a retrospective study of 31 cases. Arch Surg. 1980 Jan;115(1):62–64. doi: 10.1001/archsurg.1980.01380010054010. [DOI] [PubMed] [Google Scholar]
  9. Howat J. M., Jones C. B., Schofield P. F. Gall-stones and oral contraceptives. J Int Med Res. 1975;3(2):59–62. doi: 10.1177/030006057500300201. [DOI] [PubMed] [Google Scholar]
  10. Jørgensen T. Gall stones in a Danish population: fertility period, pregnancies, and exogenous female sex hormones. Gut. 1988 Apr;29(4):433–439. doi: 10.1136/gut.29.4.433. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Kern F., Jr, Everson G. T., DeMark B., McKinley C., Showalter R., Braverman D. Z., Szczepanik-Van Leeuwen P., Klein P. D. Biliary lipids, bile acids, and gallbladder function in the human female: effects of contraceptive steroids. J Lab Clin Med. 1982 Jun;99(6):798–805. [PubMed] [Google Scholar]
  12. Layde P. M., Vessey M. P., Yeates D. Risk factors for gall-bladder disease: a cohort study of young women attending family planning clinics. J Epidemiol Community Health. 1982 Dec;36(4):274–278. doi: 10.1136/jech.36.4.274. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Maringhini A., Marcenò M. P., Lanzarone F., Caltagirone M., Fusco G., Di Cuonzo G., Cittadini E., Pagliaro L. Sludge and stones in gallbladder after pregnancy. Prevalence and risk factors. J Hepatol. 1987 Oct;5(2):218–223. doi: 10.1016/s0168-8278(87)80576-7. [DOI] [PubMed] [Google Scholar]
  14. Matolo N. M., LaMorte W. W., Wolfe B. M. Acute and chronic cholecystitis. Surg Clin North Am. 1981 Aug;61(4):875–883. doi: 10.1016/s0039-6109(16)42485-0. [DOI] [PubMed] [Google Scholar]
  15. Maurer K. R., Everhart J. E., Knowler W. C., Shawker T. H., Roth H. P. Risk factors for gallstone disease in the Hispanic populations of the United States. Am J Epidemiol. 1990 May;131(5):836–844. doi: 10.1093/oxfordjournals.aje.a115574. [DOI] [PubMed] [Google Scholar]
  16. Miettinen O. S., Caro J. J. Principles of nonexperimental assessment of excess risk, with special reference to adverse drug reactions. J Clin Epidemiol. 1989;42(4):325–331. doi: 10.1016/0895-4356(89)90037-1. [DOI] [PubMed] [Google Scholar]
  17. Miettinen O. Estimability and estimation in case-referent studies. Am J Epidemiol. 1976 Feb;103(2):226–235. doi: 10.1093/oxfordjournals.aje.a112220. [DOI] [PubMed] [Google Scholar]
  18. Mok H. Y., Druffel E. R., Rampone W. M. Chronology of cholelithiasis. Dating gallstones from atmospheric radiocarbon produced by nuclear bomb explosions. N Engl J Med. 1986 Apr 24;314(17):1075–1077. doi: 10.1056/NEJM198604243141703. [DOI] [PubMed] [Google Scholar]
  19. Pannwitz H., Nürnberg D., Berndt H. Zur Epidemiologie von Gallenblasensteinen (GS) bei jungen Frauen. Leber Magen Darm. 1990 Jul;20(4):189-92, 194. [PubMed] [Google Scholar]
  20. Petitti D. B., Friedman G. D., Klatsky A. L. Association of a history of gallbladder disease with a reduced concentration of high-density-lipoprotein cholesterol. N Engl J Med. 1981 Jun 4;304(23):1396–1398. doi: 10.1056/NEJM198106043042305. [DOI] [PubMed] [Google Scholar]
  21. Sastic J. W., Glassman C. I. Gallbladder disease in young women. Surg Gynecol Obstet. 1982 Aug;155(2):209–211. [PubMed] [Google Scholar]
  22. Scragg R. K., McMichael A. J., Seamark R. F. Oral contraceptives, pregnancy, and endogenous oestrogen in gall stone disease--a case-control study. Br Med J (Clin Res Ed) 1984 Jun 16;288(6433):1795–1799. doi: 10.1136/bmj.288.6433.1795. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Sichieri R., Everhart J. E., Roth H. P. Low incidence of hospitalization with gallbladder disease among blacks in the United States. Am J Epidemiol. 1990 May;131(5):826–835. doi: 10.1093/oxfordjournals.aje.a115573. [DOI] [PubMed] [Google Scholar]
  24. Sorf M., Krislo V., Sulek P., Krsák S., Krislová M., Mach M., Masek O., Volár F. Zvysujú perorálne kontraceptíva riziko vzniku cholelitiáz? Cesk Gynekol. 1987 Jul;52(6):434–437. [PubMed] [Google Scholar]
  25. Stolley P. D., Tonascia J. A., Tockman M. S., Sartwell P. E., Rutledge A. H., Jacobs M. P. Thrombosis with low-estrogen oral contraceptives. Am J Epidemiol. 1975 Sep;102(3):197–208. doi: 10.1093/oxfordjournals.aje.a112148. [DOI] [PubMed] [Google Scholar]
  26. Strom B. L., Tamragouri R. N., Morse M. L., Lazar E. L., West S. L., Stolley P. D., Jones J. K. Oral contraceptives and other risk factors for gallbladder disease. Clin Pharmacol Ther. 1986 Mar;39(3):335–341. doi: 10.1038/clpt.1986.49. [DOI] [PubMed] [Google Scholar]
  27. Thijs C., Knipschild P., Leffers P. Pregnancy and gallstone disease: an empiric demonstration of the importance of specification of risk periods. Am J Epidemiol. 1991 Jul 15;134(2):186–195. doi: 10.1093/oxfordjournals.aje.a116071. [DOI] [PubMed] [Google Scholar]
  28. Thijs C., Knipschild P., van Engelshoven J. The prevalence of gallstone disease in a Dutch population. Scand J Gastroenterol. 1990 Feb;25(2):155–160. doi: 10.3109/00365529009107937. [DOI] [PubMed] [Google Scholar]
  29. Vandenbroucke J. P. Passive smoking and lung cancer: a publication bias? Br Med J (Clin Res Ed) 1988 Feb 6;296(6619):391–392. doi: 10.1136/bmj.296.6619.391. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Vessey M., Doll R., Peto R., Johnson B., Wiggins P. A long-term follow-up study of women using different methods of contraception--an interim report. J Biosoc Sci. 1976 Oct;8(4):373–427. doi: 10.1017/s0021932000010890. [DOI] [PubMed] [Google Scholar]
  31. Williams C. N., Johnston J. L. Prevalence of gallstones and risk factors in Caucasian women in a rural Canadian community. Can Med Assoc J. 1980 Mar 22;122(6):664–668. [PMC free article] [PubMed] [Google Scholar]
  32. Wysowski D. K., Goldberg E. L., Comstock G. W., Diamond E. L. A study of a possible association between breast cancer and gallbladder disease. Am J Epidemiol. 1986 Mar;123(3):532–543. doi: 10.1093/oxfordjournals.aje.a114268. [DOI] [PubMed] [Google Scholar]
  33. van Beek E. J., Farmer K. C., Millar D. M., Brummelkamp W. H. Gallstone disease in women younger than 30 years. Neth J Surg. 1991 Jun;43(3):60–62. [PubMed] [Google Scholar]
  34. van der Werf S. D., van Berge Henegouwen G. P., Ruben A. T., Palsma D. M. Biliary lipids, bile acid metabolism, gallbladder motor function and small intestinal transit during ingestion of a sub-fifty oral contraceptive. J Hepatol. 1987 Jun;4(3):318–326. doi: 10.1016/s0168-8278(87)80540-8. [DOI] [PubMed] [Google Scholar]

Articles from American Journal of Public Health are provided here courtesy of American Public Health Association

RESOURCES